OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pressure during 24 hours (ambulatory blood pressure monitoring), on left ventricular mass, and on antihypertensive therapy in 86 obese and hypertensive patients for 6 months. METHODS: The patients underwent echocardiography, ambulatory blood pressure monitoring, and measurement of the levels of hepatic enzymes prior to and after treatment with sibutramine or placebo. RESULTS: The group using sibutramine had a greater weight loss than that using placebo (6.7% versus 2.5%; p<0.001), an increase in heart rate (78.3±7.3 to 82±7.9 bpm; p=0.02), and a reduction in the left ventricular mass/height index (105±29.3 versus 96.6±28.58 g/m; p=0.002). Both ...
Background: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
Objective: the objective of this study is to assess the effects of sibutramine on body weight, body ...
OBJECTIVE: Sibutramine, a serotonin and norepinephrine transporter inhibitor, is widely used as a...
Obesity and hypertension are closely associated risk factors for cardiovascular disease. An increase...
Background Sibutramine, a serotonin and norepinephrine transporter blocker, is a common adjunctive ...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
This is a double-blind, placebo-controlled study of the efficacy, safety, and tolerability of sibutr...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
Background: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
OBJECTIVE: To assess the effects of weight reduction with 10mg of sibutramine or placebo on blood pr...
Objective: the objective of this study is to assess the effects of sibutramine on body weight, body ...
OBJECTIVE: Sibutramine, a serotonin and norepinephrine transporter inhibitor, is widely used as a...
Obesity and hypertension are closely associated risk factors for cardiovascular disease. An increase...
Background Sibutramine, a serotonin and norepinephrine transporter blocker, is a common adjunctive ...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
This is a double-blind, placebo-controlled study of the efficacy, safety, and tolerability of sibutr...
AIM: The aim of our study was to comparatively evaluate the efficacy and safety of orlistat and sibu...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular eve...
Background: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...
BACKGROUND: The long-term effects of sibutramine treatment on the rates of cardiovascular events and...